Mots-clés
Documents disponibles dans cette catégorie (685)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Etendre la recherche sur niveau(x) vers le bas
Article
Pfeffer G ; Chinnery PF | 14/04/2022Initial Posting: February 27, 2014; Last Update: April 14, 2022. Clinical characteristics. Hereditary myopathy with early respiratory failure (HMERF) is a slowly progressive myopathy that typically begins in the third to fifth decades of l[...]Article
Hershberger RE ; Jordan E | 07/04/2022Initial Posting: July 27, 2007; Last Update: April 7, 2022. The purpose of this overview is to increase clinician awareness of the genetic basis of dilated cardiomyopathy (DCM) and the benefits of early diagnosis and management to individuals[...]Article
Article
Initial Posting: September 5, 2000; Last Revision: January 20, 2022. Clinical characteristics. The dystrophinopathies cover a spectrum of X-linked muscle disease ranging from mild to severe that includes Duchenne muscular dystrophy, Becker[...]Article
Last Update: January 9, 2022 (previous version August 14, 2021; August 15, 2020)Article
Crefcoeur LL ; Visser G ; Ferdinandusse S ; Wijburg FA ; Langeveld M ; Sjouke B | United States | 08/01/2022Article
Schreuder AB ; Rossi A ; Grünert SC ; Derks TGJ | 06/01/2022Initial Posting: March 9, 2010; Last Update: January 6, 2022. Clinical characteristics. Glycogen storage disease type III (GSD III) is characterized by variable liver, cardiac muscle, and skeletal muscle involvement. GSD IIIa is the most c[...]Article
Abicht A ; Müller J ; Lochmuller H | 23/12/2021Initial Posting: May 9, 2003; Last Update: December 23, 2021. The purpose of this overview is to increase the awareness of clinicians regarding congenital myasthenic syndromes (CMS) and their genetic causes and management. The following ar[...]Article
Comi GP ; Niks EH ; Cinnante CM ; Kan HE ; Vandenborne K ; Willcocks RJ ; Velardo D ; Ripolone M ; van Benthem JJ ; van de Velde NM ; Nava S ; Ambrosoli L ; Cazzaniga S ; Bettica PU | United States | 16/12/2021Article
Opal P | 14/10/2021Initial Posting: January 9, 2003; Last Update: October 14, 2021. Clinical characteristics. GAN-related neurodegeneration comprises a phenotypic continuum ranging from severe (sometimes called classic giant axonal neuropathy) to milder pure[...]Article
Article
Article
Article
Thebault S ; Gibbs E ; Bourque P ; McKim D ; Rakhra K ; Breiner A ; Frykman H ; Warman-Chardon J | England | 06/09/2021Article
Article
Juntas Morales R ; Perrin A ; Sole G ; Lacourt D ; Pegeot H ; Walther Louvier U ; Cintas P ; Cances C ; Espil C ; Theze C ; Zenagui R ; Yauy K ; Cosset E ; Renard D ; Rigau V ; Maues de Paula A ; Uro-Coste E ; Arne-Bes MC ; Martin Negrier ML ; Leboucq N ; Acket B ; Malfatti E ; Biancalana V ; Metay C ; Richard P ; Rendu J ; Rivier F ; Koenig M ; Cossee M | 31/07/2021Article
Initial Posting: June 8, 2000; Last Update: July 29, 2021.Article
Baumbach-Reardon L ; Hunter JM ; Ahearn ME ; Pfautsch M | 29/07/2021Initial Posting: October 30, 2008; Last Update: July 29, 2021.Article
Article
Jayarangaiah A ; Theetha Kariyanna P | 15/07/2021Last Update: July 15, 2021. (previous version July 15, 2020)Article
Last Update: July 14, 2021. (previous version November 19, 2020)Article
Last Update: July 8, 2021. (previous version July 8, 2021)